Pfizer sells Vicuron pipeline to new start-up Durata
This article was originally published in Scrip
Executive Summary
Pfizer has sold its Vicuron Pharmaceuticals business to the newly formed Durata Therapeutics in a stock deal funded by a syndicate of venture capitalists for an undisclosed amount.